Fig. 11. Role of endothelial dysfunction in the progression of chronic cardiac failure. The diagram depicts the four major underlying and mutually interacting.

Slides:



Advertisements
Similar presentations
HEART FAILURE (HF) Heart failure is the pathophysiological state in which an abnormality of cardiac function is responsible for failure of the heart to.
Advertisements

Heart Failure (CHF) Brunner, ch. 30, pp
Congestive Heart Failure
Hemodynamic Disorders Dr. Raid Jastania. Intended Learning Outcomes 1.Students should be able to define edema, congestion, hemorrhage, thrombosis and.
Blood Pressure.
Congestive Heart Failure
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 43 Review of Hemodynamics.
Neurohormonal Activation especially AVP in Congestive Heart Failure 陈宇寰 丁 宁 高 柳 郭华秋 韩国嵩 臧 鹏.
Heart Failure, Shock and Hemodynamics Howard Sacher D.O. Long Island Cardiology.
Cardiovascular system in its context Reverend Dr. David C.M. Taylor School of Medical Education
Endocrine control of osmolarity Antidiuretic hormone (ADH) Aldosterone Atrial natriuretic peptide (ANP)
Drugs Used In the Treatment of Congestive Heart Failure(Cont) Garrett J. Gross, Ph.D. Drugs Used In the Treatment of Congestive Heart Failure(Cont) Garrett.
1 Cardiac Pathophysiology Part B. 2 Heart Failure The heart as a pump is insufficient to meet the metabolic requirements of tissues. Can be due to: –
Bio-Med 350 Normal Heart Function and Congestive Heart Failure.
Heart failure Results from any structural or functional cardiac disorder that impairs the ability of the ventricle to fill with or eject blood to meet.
Cardiac Output When the heart contracts Cardiac Vocabulary Contractility: Contractility is the intrinsic ability of cardiac muscle to develop force for.
Jung/Johnny Sin Summer Intern 2012 Advanced Heart Failure.
Drugs for Congestive Heart Failure BACKGROUND DEFINITION: The inability of heart to meet the needs of peripheral systems. PATHOGENY: myocardium contraction.
Drugs for Heart Failure
CARDIAC AND VASCULAR FUNCTION CURVES.. Figure Length-force relationships in intact heart: a Frank-Starling curve Optimal Length.
Treatment of Heart Failure Claire Hunter, MD. Treatment of Heart Failure Goals Improve quality of life Prolong life Ejection fraction most important.
 By the end of this lecture the students are expected to:  Understand the concept of preload and afterload.  Determine factors affecting the end-diastolic.
Medical Progress: Heart Failure. Primary Targets of Treatment in Heart Failure. Treatment options for patients with heart failure affect the pathophysiological.
Cardiovascular hormones Dr J Ker. Previous lecture: Mechanical aspects, blood pressure, formulas… Previous lecture: Mechanical aspects, blood pressure,
Drugs for Congestive Heart Failure
kvs1ed.ppt 1 Heart and Circulatory Failure Lectures from Pathological Physiology Dental Medicine Study materials from Pathological Physiology,
PROF. AZZA El-Medany Department of Pharmacology OBJECTIVES At the end of lectures the students should Describe the different classes of drugs used for.
The Renin-Angiotensin System
From Finch to Fish to Man: Role of Body Fluid Volume Regulation Robert W. Schrier, MD Professor of Medicine University of Colorado School of Medicine.
Heart Failure Claire B. Hunter, MD. Heart Failure is the inability of the heart to pump sufficient blood to the body tissue to meet ordinary metabolic.
Bipyridines :(Amrinone,Milrinone ) only available in parenteral form. Half-life 3-6hrs. Excreted in urine.
Congestive Heart Failure Arun Abbi M.D.. Outline 1. Classification and epidemiology 2. Pathophysiology 3. Diagnosis 4. Treatment 5. Conclusions.
Human Anatomy and Physiology
Heart Failure - I Pathophysiology Dr Hanan ALBackr 3/11/1429(1/11/2008)
Heart failure Laszlo L. Tornoci Inst. Pathophysiology Semmelweis University.
Physiology of Ventricular Function Dr. Chris Glover Interventional Cardiology Director of Education University of Ottawa Heart Institute January 12, 2015.
Basic Science Series: Pathophysiology of Heart Failure October 27/2009.
HEART FAILURE Institute of Pathological Physiology Martin Vokurka WS 2008/09.
Congestive Heart Failure Dory Roedel Ferraro, DNP, ANP-BC, CBN.
Lecture # 39 HEMODYNAMICS - 7 Dr. Iram Sohail Assistant Professor Pathology College Of Medicine Majmaah University.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.1 Review of Hemodynamics Elsevier Inc. items and derived items © 2010.
Date of download: 7/9/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Role of the Natriuretic Peptide System in Cardiorenal.
Date of download: 9/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: Angiotensin II type 1 receptor antagonist decreases.
Result from any structural or functional cardiac disorder that impairs the ability of the ventricle to fill with or eject blood to meet the body's metabolic.
Pharmacotherapy Of Cardiovascular Disorders: Heart Failure
Heart Failure NURS 241 Chapter 35 (p.797).
Heart and Circulatory Failure
Drugs used for Congestive Heart Failure
Prof. Abdulrahman Al-Motrefi
Atrial Natriuretic Peptides [ANP]
به نام خدا Dominant Role of the Kidney in Long-Term Regulation of Arterial Pressure and in Hypertension: The Integrated System for Pressure Control.
Principles of Cardiac dysfunction
Fig. 8. Changes of caspase-3 (A), Bcl-2 (B), IL-6 (C), TNF-α (D), VEGF (E) and BNP (F) protein expression levels after hUCB-MSCs injection in PAH rat heart.
Sympathetic stimulation of the kidney leads to the release of renin, with a resultant increase in the circulating levels of angiotensin II and aldosterone.
Left Ventricular Dysfunction With Pulmonary Hypertension
Heart Failure Cooper University Hospital School of Perfusion 2015
Section III: Neurohormonal strategies in heart failure
The pathophysiology of myocardial infarction-induced heart failure
PATHOPHYSIOLOGY OF HEART FAILURE
CIRCULATORY HEART FAILURE (CHF)‏
Congestive Heart Failure
Heart failure and cognitive dysfunction
Eugene Braunwald JCHF 2013;1:1-20
Atrial Natriuretic Peptides [ANP]
Therapeutic Strategies for Heart Failure in Cardiorenal Syndromes
Fig. 1. Cardiac, i.e., endocardial (EE) and myocardial capillary (MyoCapE), endothelium and myocardium. The ventricular wall (inset) consists of the epicardium,
Fig. 5. Reciprocal signaling between cardiac endothelial cells and cardiomyocytes influences myocardial growth, contractile performance, and rhythmicity.
Paul A. Gurbel, and Udaya S. Tantry JCHF 2014;2:1-14
β-Blocker Use for the Stages of Heart Failure
Cardiovascular System
Presentation transcript:

Fig. 11. Role of endothelial dysfunction in the progression of chronic cardiac failure. The diagram depicts the four major underlying and mutually interacting pathophysiological mechanisms.1) Hemodynamic abnormality includes cardiac dysfunction and overloading (increased pre- and afterload) with cardiac dilatation (Starling) and remodeling (hypertrophy), cardiac muscle (decreased myocardial contractility), and pump failure leading to congestive heart failure (CHF) and death. 2) Neurohormonal imbalance includes increased plasma levels of catecholamines, renin-angiotensin-aldosterone, antidiuretic hormone, atrial and brain natriuretic peptide, prostaglandins, and dopamine. 3) Cytokine activation includes overexpression and detrimental effects of various cytokines, as, e.g., tumor necrosis factor-α (TNF-α) and interleukin-1 and -6 (IL-1, IL-6), on both myocardium and vascular and cardiac endothelium. 4) Endothelial activation-dysfunction-failure involves the entire vascular endothelial system (VE dysf), but most in particular cardiac (EE and MyoCapE) endothelial dysfunction. %Percentage of cardiac output at rest exposed to VE surface. DOI: (10.1152/physrev.00017.2002)